Harrow Health, Inc.
Harrow Health, Inc. (HROW) Stock Overview
Explore Harrow Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
-246.50
EPS (TTM)
$-0.14
ROE
-0.10%
HROW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Harrow Health, Inc. (HROW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 30.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -246.50 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.